Preventive role of green tea catechins from obesity and related disorders especially hypercholesterolemia and hyperglycemia
© Ahmad et al.; licensee BioMed Central. 2015
Received: 15 January 2015
Accepted: 12 February 2015
Published: 4 March 2015
During the last few years, scientific investigations have proposed diet based regimens to prevent several health ailments including obesity, hypercholesterolemia and diabetes. In this regard, a promising tool is the use of functional foods/nutraceuticals. Present research project was an attempt to explore nutraceutical worth of locally grown green tea variety (Qi-Men) against lifestyle related disorders.
Functional drinks (T2 and T3) were prepared by adding catechins and epigallocatechin gallate (EGCG) @ 550 mg/500 mL and compared with control (T1). These functional drinks were tested in experimental rats modeling (Sprague Dawley). Based on diets, four studies were conducted i.e. trial-I (normal diet), trial-II (high cholesterol diet), trial-III (high sucrose diet), trial-IV (high cholesterol + high sucrose diet). Rats were monitored daily for their feed and drink intake while body weight was measured on weekly basis. After period of 56 days rats were sacrificed and evaluated their serum lipid (cholesterol, LDL and HDL), glucose and insulin levels.
Results for feed consumption by rats revealed that highest feed intake was recorded in group provided control drink than other groups. However, non significant differences were noted among all groups for drink consumption. Functional drinks resulted in significant reduction in body weight with maximum lowering noted in trial-II and III i.e. 10.73 to 8.49% and 10.12 to 10.49%, respectively. Likewise, cholesterol and LDL were substantially reduced with 14.42% decrease observed in trial-IV and 30.43% in trial-II, respectively. Furthermore, serum glucose and insulin levels were also lowered significantly in the trial-III and IV while in trial-I and II differences were non-significant. In contrast to lipid profile, experimental drink containing EGCG reduced the trait better than catechins based functional drink.
The drinks supplemented with catechins and EGCG are effective against obesity, hypercholesterolemia and hyperglycemia.
KeywordsGreen tea Functional drink Catechins EGCG Hypercholesterolemia Hyperglycemia
Changing lifestyle and poor dietary habits of people often lead to development of various maladies like obesity, diabetes, dyslipidemia and immune dysfunction. Obesity is now well-known as one of the global concerns because it is not only prevalent in the developed nations but also becoming common in the developing world with associated physiological threats. Dyslipidemia is more frequent in obese people with raised levels of LDL, triglycerides and cholesterol. Among contributory factors of obesity, dietary habits are considered one of reasons for its expansion. During the last few years, amplified consumption of carbohydrate and animal fat has contributed to increased incidence of atherosclerosis induced cardiovascular complications and diabetes mellitus. High cholesterol diet causes significant increase in serum cholesterol level along with sensitivity to oxidation. Sucrose rich diet induces hyper-triglyceridemia and hypercholesterolemia .
Phytochemicals are endemic in the human diet from the ancient times to fight against diseases as most of the medicines have been derived from plants. In the recent era, diet based therapy has been revitalized globally and people are adopting the approach of using natural materials as an intervention against various ailments. During the last few years, scientific investigations have proposed several modules like diet based regimen to prevent life threatening disorders including obesity, hypercholesterolemia and diabetes. Among these strategies, a promising tool is the use of functional/nutraceuticals foods that not only improve consumer health and wellness but also reduce disease risk with minimal cost. Green tea (Camellia sinensis) belonging to family Theaceae is one such example of functional drinks containing bioactive molecules holding cure against various diseases. Green tea contains appreciable amounts of phytochemicals especially catechins . According to literature, dried tea leaves mainly contain 10–25% polyphenols mainly belonging to various classes i.e. flavonols and, flavonoids, and flavondiols. Green tea catechins are further comprised of different chemical moieties that inlcue epigallocatechin-3-gallate (EGCG), epicatechin (EC), epicatechin-3-gallate (ECG), epigallocatechin (EGC). Amongst these, EGCG is present in higher amounts and considered to be an effective antioxidant with appreciable radical scavenging abilities .
Owing to the prophylactic role of green tea, its consumption is escalating in the vulnerable segments to cope with health disorders thus besides being a traditional beverage acts as an intervention against various physiological threats. Keeping in view the lifestyle disorders, present project was designed to use locally grown green tea variety Qi-Men with special reference to its active ingredient namely catechins. Concurrently, functional drinks containing the health ingredients i.e. catechins and EGCG were the limelight of the present research investigation. The therapeutic role of functional drinks was explored against lifestyle disorders.
Functional drink preparation
Functional drinks (T2 and T3) were prepared by addition of catechins and epigallocatechin gallate (EGCG) respectively. A control drink, T1 (without active ingredient) was also prepared for comparison purpose. Other ingredients included aspartame, citric acid, sodium benzoate, carboxy methyl cellulose (CMC), food grade color and flavor. After processing of drinks, active ingredients including catechins and EGCG were added individually @ 550 mg/500 mL in respective drinks. Briefly, catechins rich fraction from green tea was separated using water at constant temperature of 40°C and concentrated through a rotary evaporator (Eyela, Japan) and dried through Vacuum Oven. Later, chloroform and ethyl acetate were used used to extract catechins from dried extracts. For extracting EGCG, water filtration followed by addition of caffeine and subsequent centrifugation at 16,600×g for 20 min was used. Later, pellet was decaffeinated and solvents (chloroform and ethyl hexanoate) fractionation was used for further separation of gallate rich moieties. The resultant aqueous fraction thus obtained was subjected to further partition with propyl acetate to get EGCG rich fraction that was further concentrated using a Rotary Evaporator and dried using Freeze Drier .
Test animals and their housing
The research received ethical approval from Animal Care Committee (ACC) of National Institute of Food Science and Technology (NIFSAT). Later, National Institute of Health (NIH) provided the researchers with 120 infectious free Sprague dawley rats for the research purpose. The rats were housed in the Animal Room of National Institute of Food Science and Technology. Four different trials depending on different types of diets i.e. trial-I (normal diet), trial-II (high cholesterol diet), trial-III (high sucrose diet) and trial-IV (high cholesterol + high sucrose diet) were conducted. Therfore, 120 rats were divided in four groups of thirty each. In each trial, rats were further divided into three subgroups comprising of ten rats in each subgroup. Rats were placed in standard polypropylene cages with stainless steel top grill. Rats were acclimatized by feeding basal diet (AIN-76A) for a period of one week. At the initiation of study some rats were sacrificed to get baseline values. The temperature (23 ± 2°C) and relative humidity (55 ± 5%) were maintained throughout the experiment with 12 hours light–dark period. Feed & drink intake was recorded daily whilst body weight on weekly basis throughout the experiment. Spilled diet and feces were also collected.
Trial-I: normal diet
Diet plan used in the studies
High cholesterol diet
High sucrose diet
High cholesterol + high sucrose diet
Trial-II: high cholesterol diet
In trial-II, high cholesterol diet containing 1% of cholesterol was distributed to the normal rats along with other ingredients provided in normal diet. The functional drinks were also provided to the rats groups simultaneously to synchronize their effect on the respective category.
Trial-III: high sucrose diet
In trial-III, high sucrose diet containing 40% sucrose was added to corn oil (10%), corn starch (26%), casein (10%), cellulose (10%) and salt & vitamin mixture (3 & 1%).
Trial-IV: high cholesterol + high sucrose diet
Rats of group IV were fed on diet including corn oil (10%), corn starch (25%), casein (10%), cellulose (10%), salt & vitamin mixture (3 & 1%), cholesterol and sucrose in amount of 1% and 40% respectively.
The following parameters were recorded separately in all rat modeling studies.
Feed and drink intake
Net feed intake of each group was measured daily by excluding spilled diet from the total diet during the entire study period . The functional drink intake of each group was also recorded daily by monitoring the differences in the graduated bottles.
Body weight gain
Gain in body weight of experimental groups was measured weekly throughout the study period to monitor suppressing effect of functional drinks on body weight gain.
Serum lipid profile
Serum cholesterol level was determined using CHOD–PAP method . High density lipoprotein (HDL) in serum samples was measured by HDL Cholesterol Precipitant method and low density lipoproteins (LDL) following the procedure of McNamara et al. . Total triglycerides were determined by liquid triglycerides (GPO–PAP) method .
Serum glucose and insulin levels
In each study, rats serum samples were evaluated for glucose concentration by GOD-PAP method as described by Thomas and Labor  whereas insulin level was assessed following the method of Besch .
Completely Randomized Design (CRD) was applied and resultant data was subjected to statistical analysis using Cohort version 6.1. Analysis of variance technique (ANOVA) was used to determine the level of significance and means were further compared through Duncan Multiple Range test.
Feed and drink intake
Effect of functional drinks on lipid profile in rats
78.64 ± 3.07a
74.73 ± 2.34b
76.46 ± 2.42ab
147.02 ± 7.83a
126.42 ± 4.47b
130.09 ± 7.77b
128.74 ± 5.60a
113.84 ± 6.93b
116.79 ± 5.36b
155.02 ± 8.36a
132.67 ± 6.90b
135.42 ± 6.33b
34.64 ± 2.57
35.80 ± 1.79
35.47 ± 2.25
56.29 ± 3.71
58.30 ± 4.47
57.80 ± 4.15
46.95 ± 2.59
48.27 ± 3.53
47.80 ± 3.43
58.86 ± 3.01
60.35 ± 4.66
59.27 ± 2.61
30.34 ± 1.43a
25.55 ± 1.22b
27.41 ± 1.46ab
69.68 ± 3.45a
48.47 ± 2.41b
52.17 ± 3.79b
64.66 ± 3.22a
50.36 ± 2.83b
52.42 ± 4.32b
74.59 ± 4.95a
53.10 ± 3.45b
57.27 ± 4.98b
68.30 ± 3.74
66.92 ± 3.61
67.89 ± 3.13
105.26 ± 6.02
98.23 ± 5.16
100.61 ± 7.71
85.63 ± 6.52a
76.06 ± 5.09b
82.86 ± 4.82ab
107.85 ± 7.21a
94.38 ± 6.05b
96.10 ± 4.69b
Glucose and insulin level
Effect of functional drinks on glucose and insulin levels of rats
93.55 ± 6.01
92.44 ± 4.43
90.44 ± 4.79
105.60 ± 6.61
103.32 ± 5.26
101.51 ± 4.58
125.93 ± 5.47a
113.21 ± 7.25b
110.40 ± 5.85b
130.05 ± 8.75a
121.07 ± 7.32b
119.57 ± 6.60b
9.33 ± 0.51
9.15 ± 0.68
9.14 ± 0.71
11.05 ± 0.09
10.59 ± 0.15
10.34 ± 0.65
14.34 ± 0.41a
12.65 ± 0.57b
12.20 ± 0.49b
16.34 ± 0.59a
14.20 ± 0.74b
13.65 ± 0.67b
In present exploration, less feed consumption due to functional drinks is supported by the work of Babu et al. . Results for drink consumption are similar to work of Yang et al. . However, Lee et al.  elucidated suppressed fluid intake in a group provided EGCG solution. The differences may be due to the fact that they used EGCG solution without toting up any additive. However, in the present case drinks were prepared by adding flavor and artificial sweetener that may be a reason for improved consumption.
The current results showing reduced body weight gain in groups consuming drinks containing catechins or EGCG are in consistent with the study of Basu et al.  and Byun et al.  Weight reduction by green tea might be due to reduced digestibility and an increase in energy expenditure and fat oxidation through β-adrenoceptor activated thermogenesis of brown adipose tissue [16,17]. Inhibited lipid absorption from meals might be other reason for reduced weight gain .
Results for decreased cholesterol and LDL levels are in consistent with the work of Kim et al. . Hypocholesterolemic potential of catechins can be accredited to increased fecal excretion of cholesterol and bile acid . Tea catechins increase the bile acid excretion by preventing reabsorption from small intestine through disruption of micelle formation of bile acid. This increased excretion of bile acid and cholesterol activates cholesterol 7α-hydroxylase that enhances the conversion of liver cholesterol to bile acid to restock this loss thus resulting in cholesterol reduction. This decrease in hepatic cholesterol content in turn stimulates LDL receptor expression and lowers blood cholesterol level .
Results for non-significant effect of drinks on HDL are in agreement with previous work of Gomikawa et al. . The effects could be due to presence of various bioactive components present in green tea . Roghani and Baluchnejadmojarad  noted LDL reduction in diabetic rat modeling with EGCG. The proposed mechanism of LDL reduction by green tea catechins is through inhibition of cholesterol synthesis and dietary cholesterol absorption . Crude catechins decrease plasma cholesterol concentrations by upregulating LDL receptor. The increase in the LDL receptor improves the uptake of low density lipoprotein cholesterol from the blood circulation . Moreover, reduced expression of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) might be another reason for hypocholesterolemic activity of green tea as green tea EGCG also inhibits HMGR activity [26,27].
Low concentration of triglycerides by green tea might result from suppressed expression of stearoyl-CoA desaturase (SCD 1) gene. Because in liver triglyceride synthesis depends on the expression of the SCD 1 gene, that is involved in biosynthesis of oleate and palmitoleate, the major monounsaturated fatty acids of triglycerides. However, Watanabe et al.  is of the view that reduced activity of acetyl-Co A by green tea catechins is a reason for low triglycerides synthesis.
Reduced glucose level by green tea is supported by the work of Polychronopoulos et al.  that stated that there occurs inverse relation between green tea and blood glucose. The antihyperglycemic effect of green tea may be due to activated uptake of glucose, inhibited intestinal glucose transporter and decreased expression of gluconeogenesis controlling genes . EGCG exhibits hypoglycemic potential by preventing the intestinal glucose absorption via sodium-dependent glucose transporter (SGLT1), lowering the expression of mRNA for gluconeogenesis controlling enzymes  and causing repression of glucose production, phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase gene expression, hepatocyte nuclear factor 1α (HNF1α), and HNF4α in cells . Additionally, EGCG has direct effect on hepatic glucose metabolism thus improving glucose stimulated insulin secretion . Attenuation of insulin level with functional drinks in current exploration is supported by the work of Hsu et al. . It is proposed that amelioration of insulin resistance by green tea is associated with increased expression of glucose transporter (GLUT) IV . It can be concluded that green tea mitigates hypercholesterolemia and hyperglycemia effectually. It has cholesterol lowering properties along with hypoinsulinemic capability that could be associated with improved insulin sensitivity.
Our study demonstrates that drinks supplemented with catechins and EGCG are effective against obesity, hypercholesterolemia and hyperglycemia. Consumption of functional drink reduced the body weight. Functional drinks resulted in significant reduction in body weight that could be caused by a decreased feed intake. Moreover, improvement in lipid profile was observed in all trials but more pronounced in semi-diseased states i.e. trial-III and trial-II. Furthermore, serum glucose and insulin levels were also lowered significantly in the trial-III and IV. It was interesting to observe that catechins showed higher potency against hypercholesterolemia but EGCG reduced the hyperglycemia more effectively.
This study was supported by Higher Education Commission (HEC), Pakistan. The authors are also thankful to Dr. Hang Xiao and Dr. Farhan Saeed for their suggestions during manuscript preparation. We thank all the members of our research team for their hard work and valuable assistance.
- Devrim E, Erguder IB, Ozbek H, Durak I. High-cholesterol diet increases xanthine oxidase and decreases nitric oxide synthase activities in erythrocytes from rats. Nutr Res. 2008;28:212–5.View ArticlePubMedGoogle Scholar
- Wu AH, Spicer D, Stanczyk FZ, Tseng CC, Yang CS, Pike MC. Effect of 2-month controlled green tea intervention on lipoprotein cholesterol, glucose, and hormone levels in healthy postmenopausal women. Cancer Prev Res. 2012;5:393–402.View ArticleGoogle Scholar
- Butt MS, Ahmad RS, Sultan MT, Qayyum MMN, Naz A. Green tea and anticancer perspectives: Updates from last decade. Crit Rev Food Sci Nutr. 2015;55:792–805.View ArticlePubMedGoogle Scholar
- Ahmad RS, Butt MS, Huma N, Sultan MT, Saeed F, Arshad MU, et al. Quantitative and qualitative portray of green tea catechins (GTC) through HPLC. Int J Food Prop. 2014;17:1626–36.View ArticleGoogle Scholar
- Wolf BW, Weisbrode SE. Safety evaluation of an extract from Salaciaoblonga. Food Chem Toxicol. 2003;41:867–74.View ArticlePubMedGoogle Scholar
- Stockbridge H, Hardy RI, Glueck CJ. Photometric determination of cholesterol (CHOD-PAP method). Ecoline® 2S, Merck KGaA, 64271 Darmstadt, Germany. J Lab Clin Med. 1989;114(2):142–51.PubMedGoogle Scholar
- McNamara JR, Cohn JS, Wilson PW, Schaefer EJ. Calculated values for low-density lipoprotein cholesterol in the assessment of lipid abnormalities and coronary disease risk. Clin Chem. 1990;36:36–42.PubMedGoogle Scholar
- Annoni G, Botasso BM, Ciaci D, Donato MF, Tripodi A. Liquid triglycerides (GPO-PAP). Lab J Res Lab Med. 1982;9:115.Google Scholar
- Thomas L, Labor U. Enzymateischer kinetischer colorimetrischer test (GOD-PAP). Biocon Diagnostik, Hecke 8, 34516 Vohl/Manenhagen, Germany. Diagnose. 1992;4:169.Google Scholar
- Besc W, Woltanski KP, Keilacker H, Diaz-Alonso JM, Schulz B, Amendt P, et al. Measurement of insulin in human sera using a new RIA kit. 1. Insulin determination in the absence of insulin antibodies–conventional assay and micro modification. Exp Clin I Endocrinol. 1987;90:264–70.View ArticleGoogle Scholar
- Babu PVA, Sabitha KE, Shyamaladevi CS. Green tea impedes dyslipidemia, lipid peroxidation, protein glycation and ameliorates Ca2 + −ATPase and Na+/K + −ATPase activity in the heart of streptozotocin-diabetic rats. Chemico Biol Interac. 2006;162:157–64.View ArticleGoogle Scholar
- Yang MH, Wang CH, Chen HL. Green, oolong and black tea extracts modulate lipid metabolism in hyperlipidemia rats fed high-sucrose diet. J Nutr Biochem. 2001;12:14–20.View ArticlePubMedGoogle Scholar
- Lee SM, Kim CW, Kim JK, Shin HJ, Baik JH. GCG-rich tea catechins are effective in lowering cholesterol and triglyceride concentrations in hyperlipidemic rats. Lipids. 2008;43:419–29.View ArticlePubMedGoogle Scholar
- Basu A, Sanchez K, Leyva MJ, Wu M, Betts NM, Aston CE, et al. Green tea supplementation affects body weight, lipids, and lipid peroxidation in obese subjects with metabolic syndrome. J Am Coll Nutr. 2010;29(1):31–40.View ArticlePubMedGoogle Scholar
- Byun JK, Yoon BY, Jhun JY, Oh HJ, Kim EK, Min JK, et al. Epigallocatechin-3-gallate ameliorates both obesity and autoinflammatory arthritis aggravated by obesity by altering the balance among CD4+ T-cell subsets. Immunol Lett. 2014;157(1–2):51–9.View ArticlePubMedGoogle Scholar
- Choo JJ. Green tea reduces body fat aceration caused by high fat diet in rats through beta adrenocepter activation of thermogenesis in brown adipose tissue. J Nutr Biochem. 2003;14:671–6.View ArticlePubMedGoogle Scholar
- Wang S, Moustaid-Moussa N, Chen L, Mo H, Shastri A, Su R, et al. Novel insights of dietary polyphenols and obesity. J Nutr Biochem. 2014;25(1):1–18.View ArticlePubMed CentralPubMedGoogle Scholar
- Chen YK, Cheung C, Reuhl KR, Liu AB, Lee MJ, Lu YP, et al. Effects of green tea polyphenol (−)-epigallocatechin-3-gallate on newly developed high-fat/western-style diet-induced obesity and metabolic syndrome in mice. J Agric Food Chem. 2011;59(21):11862–71.View ArticlePubMed CentralPubMedGoogle Scholar
- Kim A, Chiu A, Barone MK, Avino D, Wang F, Coleman CI, et al. Green tea catechins decrease total and low-density lipoprotein cholesterol: a systematic review and meta-analysis. J Am Diet Assoc. 2011;111:1720–9.View ArticlePubMedGoogle Scholar
- Yang TT, Koo MW. Chinese green tea lowers cholesterol level through an increase in fecal lipid excretion. Life Sci. 2000;66:411–23.View ArticlePubMedGoogle Scholar
- Goto T, Saito Y, Morikawa K, Kanamaru Y, Nagaoka S. Epigallocatechin gallate changes mRNA expression level of genes involved in cholesterol metabolism in hepatocytes. Br J Nutr. 2012;107(6):769–73.View ArticlePubMedGoogle Scholar
- Gomikawa S, Ishikawa Y, Hayase W, Haratake Y, Hirano N, Matuura H, et al. Effect of ground green tea drinking for 2 weeks on the susceptibility A of plasma and LDL to the oxidation ex vivo in healthy volunteers. Kobe J Med Sci. 2008;54(1):62–72.Google Scholar
- Roghani M, Baluchnejadmojarad T. Hypoglycemic and hypolipidemic effect and antioxidant activity of chronic epigallocatechin-gallate in streptozotocin-diabetic rats. Pathophysiology. 2010;17:55–9.View ArticlePubMedGoogle Scholar
- Van Heek M, Farley C, Compton DS, Hoos L, Alton KB, Sybertz EJ, et al. Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663. Br J Pharm. 2000;129:1748–54.View ArticleGoogle Scholar
- Bursill CA, Abbey M, Roach PD. A green tea extract lowers plasma cholesterol by inhibiting cholesterol synthesis and upregulating the LDL receptor in the cholesterol-fed rabbit. Atherosclerosis. 2007;193:86–93.View ArticlePubMedGoogle Scholar
- Cuccioloni M, Mozzicafreddo M, Spina M, Tran CN, Falconi M, Eleuteri AM, et al. Epigallocatechin-3-gallate potently inhibits the in vitro activity of hydroxy-3-methyl-glutaryl-CoA reductase. J Lipid Res. 2011;52(5):897–907.View ArticlePubMed CentralPubMedGoogle Scholar
- Kim YJ, Houng SJ, Kim JH, Kim YR, Ji HG, Lee SJ. Nanoemulsified green tea extract shows improved hypocholesterolemic effects in C57BL/6 mice. J Nutr Biochem. 2012;23(2):186–91.View ArticlePubMedGoogle Scholar
- Watanabe J, Kawabata J, Nidi R. Isolation and identification of acetyl-Co A carboxylase inhibitors from green tea. Biosci Biotechnol Biochem. 1998;62:532–4.View ArticlePubMedGoogle Scholar
- Polychronopoulos E, Zeimbekis A, Kastorini CM, Papairakleous N, Vlachou I, Bountziouka V, et al. Effects of black and green tea consumption on blood glucose levels in non-obese elderly men and women from Mediterranean Islands (MEDIS epidemiological study). Eur J Nutr. 2008;47(1):10–6.View ArticlePubMedGoogle Scholar
- Yasui K, Tanabe H, Miyoshi N, Suzuki T, Goto S, Taguchi K, et al. Effects of (−)-epigallocatechin-3-O-gallate on expression of gluconeogenesis-related genes in the mouse duodenum. Biomed Res. 2011;32(5):313–20.View ArticlePubMedGoogle Scholar
- Koyama Y, Abe K, Sano Y, Ishizaki Y, Njelekela M, Shoji Y, et al. Effects of green tea on gene expression of hepatic gluconeogenic enzymes in vivo. Planta Med. 2004;70:1100–2.View ArticlePubMedGoogle Scholar
- Wolfram S, Raderstorff D, Preller M, Wang Y, Teixeria SR, Riegger C, et al. Epigallocatechin gallate supplementation alleviates diabetes in rodents. J Nutr. 2006;136:2512–8.PubMedGoogle Scholar
- Hsu CH, Liao YL, Lin SC, Tsai TH, Huang CJ, Chou P. Does supplementation with green tea extract improve insulin resistance in obese type 2 diabetics? A randomized, double-blind, and placebo-controlled clinical trial. Altern Med Rev. 2011;16(2):157–63.View ArticlePubMedGoogle Scholar
- Yan J, Zhao Y, Suo S, Liu Y, Zhao B. Green tea catechins ameliorate adipose insulin resistance by improving oxidative stress. Free Radic Biol Med. 2012;52(9):1648–57.View ArticlePubMedGoogle Scholar
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.